Concomitant Immunosuppressive Therapy Use in Eculizumab-Treated Adults With Generalized Myasthenia Gravis During the REGAIN Open-Label Extension Study

Introduction: Chronic, broad-spectrum immunosuppressive therapy (IST) can be associated with side effects in many people with generalized myasthenia gravis (gMG), and treatment guidelines recommend that the IST dose be tapered once patients achieve a stable treatment response. We therefore examined...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowak, Richard J., Muppidi, Srikanth, Beydoun, Said R., O'Brien, Fanny L., Yountz, Marcus, Howard, James F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732596/
https://www.ncbi.nlm.nih.gov/pubmed/33329303
http://dx.doi.org/10.3389/fneur.2020.556104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732596/
https://www.ncbi.nlm.nih.gov/pubmed/33329303
http://dx.doi.org/10.3389/fneur.2020.556104

Ejemplares similares